{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:55:04Z","timestamp":1778788504421,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nefro.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T08:40:42Z","timestamp":1632127242000},"page":"722-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["S\u00edndrome nefr\u00f3tico como manifestaci\u00f3n de microangiopat\u00eda tromb\u00f3tica secundaria al uso cr\u00f3nico de sunitinib"],"prefix":"10.1016","volume":"42","author":[{"given":"John Fredy","family":"Nieto-R\u00edos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo Andr\u00e9s","family":"Garc\u00eda-Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arbey","family":"Aristizabal-Alzate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Zuluaga-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahyana","family":"Cadavid-Aljure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina Maria","family":"Serna-Higuita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2021.08.004_bib0110","unstructured":"Cattran D, Sheridan A, McGrath M. Primary and secondary glomerular diseases. En: Nephrology Self-Assessment Program. 2020; 19(2)."},{"key":"10.1016\/j.nefro.2021.08.004_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nefro.2018.10.016","article-title":"Onco-nephrology: Cancer, chemotherapy and kidney","volume":"39","author":"De Francisco","year":"2019","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2021.08.004_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3904\/kjim.2014.29.1.40","article-title":"Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea","volume":"29","author":"Baek","year":"2014","journal-title":"Korean J Intern Med."},{"key":"10.1016\/j.nefro.2021.08.004_bib0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.ajkd.2019.09.011","article-title":"Chronic microangiopathy due to DCR-MYC, a Myc-targeted short interfering RNA","volume":"75","author":"Miller","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2021.08.004_bib0130","first-page":"154","article-title":"Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation","volume":"1","author":"Levey","year":"2008","journal-title":"NDT Plus."},{"key":"10.1016\/j.nefro.2021.08.004_bib0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): An 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.nefro.2021.08.004_bib0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2008.288","article-title":"The case \/progressive hypertension and proteinuria on anti-angiogenic therapy","volume":"74","author":"Obhrai","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2021.08.004_bib0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0973-1482.172575","article-title":"Sunitinib-induced thrombotic microangiopathy","volume":"12","author":"Noronha","year":"2016","journal-title":"J Cancer Res Ther."},{"key":"10.1016\/j.nefro.2021.08.004_bib0150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.2015.30","article-title":"New drug toxicities in the onco-nephrology world","volume":"87","author":"Perazella","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2021.08.004_bib0155","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/his.13716","article-title":"Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy","volume":"73","author":"Pfister","year":"2018","journal-title":"Histopathology."},{"key":"10.1016\/j.nefro.2021.08.004_bib0160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/djm311","article-title":"A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib","volume":"100","author":"Patel","year":"2008","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.nefro.2021.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/annonc\/mdm454","article-title":"Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome","volume":"18","author":"Kapiteijn","year":"2007","journal-title":"Ann Oncol."},{"key":"10.1016\/j.nefro.2021.08.004_bib0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Bollee","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.08.004_bib0175","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ndt\/gfp666","article-title":"Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy","volume":"25","author":"Costero","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.08.004_bib0180","doi-asserted-by":"crossref","first-page":"c312","DOI":"10.1159\/000319885","article-title":"Nephrotoxicities associated with the use of tyrosine kinase inhibitors: A single-center experience and review of the literature","volume":"117","author":"Jhaveri","year":"2011","journal-title":"Nephron Clin Pract."},{"key":"10.1016\/j.nefro.2021.08.004_bib0185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfn625","article-title":"Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?","volume":"24","author":"Winn","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.08.004_bib0190","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1345\/aph.1R160","article-title":"Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor","volume":"46","author":"Turan","year":"2012","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.nefro.2021.08.004_bib0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2021.08.004_bib0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(07)70037-2","article-title":"Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma","volume":"8","author":"Frangie","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.nefro.2021.08.004_bib0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10157-011-0543-9","article-title":"Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction","volume":"16","author":"Takahashi","year":"2012","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.nefro.2021.08.004_bib0210","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/MJT.0b013e3181eefe8b","article-title":"Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome","volume":"19","author":"Talebi","year":"2012","journal-title":"Am J Ther."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T20:01:57Z","timestamp":1732046517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699521001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0211699521001831"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2021.08.004","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome nefr\u00f3tico como manifestaci\u00f3n de microangiopat\u00eda tromb\u00f3tica secundaria al uso cr\u00f3nico de sunitinib","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}